KRAS G13D peptide,25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide,25 mer can be used to prepare KRAS vaccine^[1] .

KRAS G13D peptide,25 mer is encoded by immunomodulatory therapeutic mRNA that can be used to prepare KRAS vaccine^[1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

2634.10

C???H???N??O??S

145019-94-9

Met-Thr-Glu-Tyr-Lys-Leu-Val-Val-Val-Gly-Ala-Gly-Asp-Val-Gly-Lys-Ser-Ala-Leu-Thr-Ile-Gln-Leu-Ile-Gln

MTEYKLVVVGAGDVGKSALTIQLIQ

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Huang EYC, et, al. Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides. WO2018144775A1.